Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsila Zuckerman

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
Leukemia Research|July 1, 2022
Re-induction versus salvage for D14-resiudal acute myeloid leukemia: A retrospective multi-center studyAvraham Frisch, Shlomzion Aumann, Tsila Zuckerman, et al.
Bone Marrow Transplantation|August 8, 2023
Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I studyJoseph P McGuirk, Leland Metheny, Luis Pineiro, et al.
Annals of Hematology|January 1, 2017
Efficacy and safety of autologous hematopoietic cell transplantation in elderly patients with multiple myeloma: a retrospective national multi-site cohort studyYael C Cohen, Tsila Zuckerman, Moshe Yeshurun, et al.
British Journal of Haematology|June 27, 2025
CCR5 predicts neurotoxicity in CAR-T-cell therapyAyal Rozenberg, Shahar Shelly, Raz Winer, et al.
American Journal of Hematology|August 1, 2012
Allogeneic stem cell transplantation for patients with chronic myeloid leukemia: risk stratified approach with a long-term follow-upTsila Zuckerman, Tamar Katz, Nuhad Haddad, et al.
The New England Journal of Medicine|April 23, 2020
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host DiseaseRobert Zeiser, Nikolas von Bubnoff, Jason Butler, et al.
Leukemia & Lymphoma|April 4, 2019
Superior outcome of patients with favorable-risk acute myeloid leukemia using consolidation with autologous stem cell transplantationOfrat Beyar-Katz, Noa Lavi, Shimrit Ringelstein-Harlev, et al.
Bone Marrow Transplantation|January 11, 2024
Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: a pilot studyIlan Youngster, Adi Eshel, Mika Geva, et al.
Annals of Hematology|December 11, 2024
In patients with follicular lymphoma, delayed-onset neutropenia induced by anti-CD20 monoclonal antibodies frequently occurs during maintenance therapy and is preferentially associated with obinutuzumabNashwa Fadaos, Yossi Ben Dor, Tehila Azoulay, et al.
Hematological Oncology|May 27, 2026
Belumosudil in the Management of Heavily Pretreated Prolonged Chronic GVHD: A Retrospective Multicenter Real-World StudyBen Varon, Ron Ram, Avichai Shimoni, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Leukemia Research|July 1, 2022
Re-induction versus salvage for D14-resiudal acute myeloid leukemia: A retrospective multi-center studyAvraham Frisch, Shlomzion Aumann, Tsila Zuckerman, et al.
Bone Marrow Transplantation|August 8, 2023
Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I studyJoseph P McGuirk, Leland Metheny, Luis Pineiro, et al.
Annals of Hematology|January 1, 2017
Efficacy and safety of autologous hematopoietic cell transplantation in elderly patients with multiple myeloma: a retrospective national multi-site cohort studyYael C Cohen, Tsila Zuckerman, Moshe Yeshurun, et al.
British Journal of Haematology|June 27, 2025
CCR5 predicts neurotoxicity in CAR-T-cell therapyAyal Rozenberg, Shahar Shelly, Raz Winer, et al.
American Journal of Hematology|August 1, 2012
Allogeneic stem cell transplantation for patients with chronic myeloid leukemia: risk stratified approach with a long-term follow-upTsila Zuckerman, Tamar Katz, Nuhad Haddad, et al.
The New England Journal of Medicine|April 23, 2020
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host DiseaseRobert Zeiser, Nikolas von Bubnoff, Jason Butler, et al.
Leukemia & Lymphoma|April 4, 2019
Superior outcome of patients with favorable-risk acute myeloid leukemia using consolidation with autologous stem cell transplantationOfrat Beyar-Katz, Noa Lavi, Shimrit Ringelstein-Harlev, et al.
Bone Marrow Transplantation|January 11, 2024
Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: a pilot studyIlan Youngster, Adi Eshel, Mika Geva, et al.
Annals of Hematology|December 11, 2024
In patients with follicular lymphoma, delayed-onset neutropenia induced by anti-CD20 monoclonal antibodies frequently occurs during maintenance therapy and is preferentially associated with obinutuzumabNashwa Fadaos, Yossi Ben Dor, Tehila Azoulay, et al.
Hematological Oncology|May 27, 2026
Belumosudil in the Management of Heavily Pretreated Prolonged Chronic GVHD: A Retrospective Multicenter Real-World StudyBen Varon, Ron Ram, Avichai Shimoni, et al.
Pageof 11